US 2024/0181031 A1 · PREPARATION OF LIVE VACCINES

Abstract

Described is a method for the generation of a live vaccine containing stable bacteria carrying at least three attenuating mutations and a vaccine containing bacteria obtained by said method.

Claims17

Dependent claims

-14. (canceled)

Dependencies are inferred from the claim text.

Facts

Application

18/441,408Filed 14 Feb 2024

Priority

EP 12008206.07 Dec 2012

Published

6 Jun 2024

Term ends

Not estimatedThe source records don’t support an estimate.

Classification19 codes

A61K 39/105
Bacterial antigens: delta proteobacteriales, e.g. Lawsonia; Epsilon proteobacteriales, e.g. campylobacter, helicobacter
A61K 39/0275
Enterobacteriales, e.g. Enterobacter: salmonella
A61P 31/04
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics: antibacterial agents
A61P 37/04
Immunomodulators: immunostimulants

Family

Application14/440,942Division · filed 6 May 2015

Application16/985,458Division · filed 5 Aug 2020

Application18/441,408Division

US 10,828,362 B2Related patent

US 11,904,008 B2Related patent

US 2015/0297705 A1Published application

US 2022/0088168 A1Published application

US 2024/0181031 A1This patent

From the US filing history. Foreign family members aren’t listed.

Abstract

Described is a method for the generation of a live vaccine containing stable bacteria carrying at least three attenuating mutations and a vaccine containing bacteria obtained by said method.

Preparation of live vaccines

Life of this patent

Abstract

Claims17

Preparation of live vaccines

Life of this patent

Abstract

Claims17